News
Kineta enters research collaboration and license agreement with Pfizer
The companies will collaborate to develop and test small molecule agonists that target RIG-I, an innate immunostimulatory pathway that can elicit immunogenic cell death (ICD) in tumors.
Bristol-Myers Squibb and Boston Medical Center collaborate to investigate markers of immuno-oncology response and resistance
The comprehensive, multi-dimensional study will place an emphasis on uncovering mechanisms associated with lack of response to Immuno-Oncology (I-O) therapies
Two ABLE BEST winners bag 2018 National Bioentrepreneurship Award
ABLE-BEST winners--KBCols Sciences and Module Innovations--win the second edition of National Bio Entrepreneurship Competition.
Dr Cyrus Poonawalla wins GAVI’s inaugural Vaccine Hero Award
Dr Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi, the Vaccine Alliance.
Serum Institute’s partner NeuClone develops mAb for breast cancer indication
NeuClone's Perjeta (pertuzumab) biosimilar is partnered with Serum Institute of India (Serum). Under the partnership, NeuClone and Serum are developing ten biosimilars for global markets.
voice for BT and BEST 2026
